Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Orchestra BioMed Holdings Inc shares valued at $126,500 were purchased by RTW INVESTMENTS, LP on Apr 29 ’25. At $2.53 per share, RTW INVESTMENTS, LP acquired 50,000 shares. The insider’s holdings grew to 8,256,163 shares worth approximately $24.52 million following the completion of this transaction.
Also, Hochman David P purchased 4,000 shares, netting a total of over 18,640 in proceeds. Following the buying of shares at $4.66 each, the insider now holds 579,498 shares.
Before that, Taylor Andrew Lawrence had added 1,000 shares to its account. In a trade valued at $4,830, the Chief Financial Officer bought Orchestra BioMed Holdings Inc shares for $4.83 each. Upon closing the transaction, the insider’s holdings increased to 1,000 shares, worth approximately $1.02 million.
As published in their initiating research note from BTIG Research on March 20, 2025, Orchestra BioMed Holdings Inc [OBIO] has been a Buy and the price target has been revised to $12. Analysts at Barclays started covering the stock with ‘”an Overweight”‘ outlook in a report released in early January. As of August 22, 2024, H.C. Wainwright has initiated its “Buy” rating for OBIO. Earlier on July 25, 2024, B. Riley Securities initiated its rating. Their recommendation was “a Buy” for OBIO stock.
Analyzing OBIO Stock Performance
During the last five days, there has been a surge of approximately 4.21%. Over the course of the year, Orchestra BioMed Holdings Inc shares have dropped approximately -25.75%. Shares of the company reached a 52-week high of $6.30 on 01/02/25 and a 52-week low of $2.43 on 04/29/25. A 50-day SMA is recorded $3.76, while a 200-day SMA reached $5.25.
Support And Resistance Levels for Orchestra BioMed Holdings Inc (OBIO)
According to the 24-hour chart, there is a support level at 2.69, which, if violated, would cause prices to drop to 2.41. In the upper region, resistance lies at 3.14. The next price resistance is at 3.31. RSI (Relative Strength Index) is 45.84 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.08, which suggests the price will decrease in the coming days. Percent R is at 34.94%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
